Do you want to skip to content? Skip to content
Contact Us Convatec Argentina Argentina Belize Belize Brasil Brasil Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Costa Rica Costa Rica Curaçao Curaçao El Salvador El Salvador Ecuador Ecuador Guatemala Guatemala Guyana Guyana Honduras Honduras Jamaica Jamaica México México Nicaragua Nicaragua Panamá Panamá Perú Perú Puerto Rico Puerto Rico República Dominicana República Dominicana Suriname Suriname Venezuela Venezuela United States (English) United States (English) België België Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Deutschland Deutschland Eesti Eesti España España France France Hrvatska Hrvatska Ireland Ireland Ísland Ísland Italia Italia Latvija Latvija Lietuva Lietuva Magyarország Magyarország Malta Malta Nederland Nederland Norge Norge Polska Polska Portugal Portugal România România Schweiz (Deutsch) Schweiz (Deutsch) Suisse (Français) Suisse (Français) Slovenija Slovenija Slovensko Slovensko Srbija Srbija Suomi Suomi Sverige Sverige Türkiye Türkiye United Kingdom United Kingdom Österreich Österreich Ελλάδα Ελλάδα България България Македонија Македонија Россия Россия Україна Україна South-Africa South-Africa ישראל ישראל الأردن الأردن الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين المملكة العربية السعودية المملكة العربية السعودية ایران ایران پاکستان پاکستان عُمان عُمان قطر قطر لبنان لبنان مصر مصر العراق العراق الكويت الكويت Australia Australia Hong Kong SAR Hong Kong SAR 中国香港 中国香港 India India Indonesia Indonesia Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Việt Nam Việt Nam ไทย ไทย 대한민국 대한민국 中国 中国 中国台湾 中国台湾 日本 日本
Convatec

Most visited pages

Reports, results and presentations
Contact Us Convatec Argentina Argentina Belize Belize Brasil Brasil Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Costa Rica Costa Rica Curaçao Curaçao El Salvador El Salvador Ecuador Ecuador Guatemala Guatemala Guyana Guyana Honduras Honduras Jamaica Jamaica México México Nicaragua Nicaragua Panamá Panamá Perú Perú Puerto Rico Puerto Rico República Dominicana República Dominicana Suriname Suriname Venezuela Venezuela United States (English) United States (English) België België Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Deutschland Deutschland Eesti Eesti España España France France Hrvatska Hrvatska Ireland Ireland Ísland Ísland Italia Italia Latvija Latvija Lietuva Lietuva Magyarország Magyarország Malta Malta Nederland Nederland Norge Norge Polska Polska Portugal Portugal România România Schweiz (Deutsch) Schweiz (Deutsch) Suisse (Français) Suisse (Français) Slovenija Slovenija Slovensko Slovensko Srbija Srbija Suomi Suomi Sverige Sverige Türkiye Türkiye United Kingdom United Kingdom Österreich Österreich Ελλάδα Ελλάδα България България Македонија Македонија Россия Россия Україна Україна South-Africa South-Africa ישראל ישראל الأردن الأردن الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين المملكة العربية السعودية المملكة العربية السعودية ایران ایران پاکستان پاکستان عُمان عُمان قطر قطر لبنان لبنان مصر مصر العراق العراق الكويت الكويت Australia Australia Hong Kong SAR Hong Kong SAR 中国香港 中国香港 India India Indonesia Indonesia Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Việt Nam Việt Nam ไทย ไทย 대한민국 대한민국 中国 中国 中国台湾 中国台湾 日本 日本

03 July 2018

Reading, United Kingdom (3 July 2018)

Convatec Group Plc “Convatec” or “the Company” has been informed by the CEO of Novo Holdings A/S (“Novo”), Kasim Kutay, of Novo’s desire to effect a rotation in its Board representative. As such, Kasim Kutay will resign his position as a Non-Executive Director of the Company with effect from 3 July 2018.

As a significant investor in Convatec, Novo is entitled to nominate one Non-Executive Director to the Board of the Company under the relationship agreement agreed on 31 March 2017 between Novo and Convatec. Accordingly, Mr Sten Scheibye will join the Board of Convatec on 3 July 2018 as a Non-Executive Director. The appointment of Mr Scheibye has been approved by the Company’s Nominations Committee and the Board.

Sten Scheibye was Chairman of the Novo Nordisk Foundation and of Novo Holdings A/S from 2013 and has recently retired from both these positions. He currently holds the position of Senior Advisor to Novo Holdings. He was appointed Chairman of Healthcare Denmark in 2015. He was a member of the Danish Corporate Governance Committee from 2003 – 2011, serving the last two years as Chairman, and from 1995 – 2008 he was the President and CEO of Coloplast A/S.

Sir Christopher Gent, Chairman of Convatec, said:

“I am delighted to welcome Sten to the Board of Convatec. He has exceptional experience of the MedTech industry, in addition to a track record of success. We look forward to his contribution”.

 

 

Enquiries

 

Media

Bobby Leach, VP Group Corporate Affairs, Convatec                

+44 (0)7770 842 226

Alastair Elwen, Finsbury                                                           

+44 (0)207 251 3801

 

Analysts and Investors

John Crosse, VP Investor Relations, Convatec                          

+44 (0)7500 141 435

Kirsty Law, Director Investor Relations, Convatec                      

+44 (0)7470 909 582

investorrelations@convatec.com

 

 

About Convatec

 

Convatec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. Convatec’s products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care.  

Press Release

See all

5/13/2022

5/13/2022

Q1 Trading Update for the three months ended 31 March 2018

Q1 Trading Update for the three months ended 31 March 2018

Read more

5/13/2022

5/13/2022

Convatec announces changes within its U.S. Home Distribution Group

Convatec announces changes within its U.S. Home Distribution Group

Read more

5/13/2022

5/13/2022

Convatec announces 2018 Interim Results

Convatec announces 2018 Interim Results

Read more

5/13/2022

5/13/2022

03 July 2018 - Board Changes

03 July 2018 - Board Changes

Read more

5/13/2022

5/13/2022

Convatec Receives U.S. FDA 510(k) Clearance for Avelle™ Negative Pressure Wound Therapy System

Convatec Receives U.S. FDA 510(k) Clearance for Avelle™ Negative Pressure Wound Therapy System

Read more

5/13/2022

5/13/2022

Trading update for the three months ended 30 September 2018 and change in FY 2018 guidance

Trading update for the three months ended 30 September 2018 and change in FY 2018 guidance

Read more

5/13/2022

5/13/2022

Retirement of Chief Executive Officer and appointment of Rick Anderson as Chief Executive Officer (Interim)

Retirement of Chief Executive Officer and appointment of Rick Anderson as Chief Executive Officer (Interim)

Read more

5/13/2022

5/13/2022

US FDA 510(k) clearance for AQUACEL™ Ag Advantage

US FDA 510(k) clearance for AQUACEL™ Ag Advantage

Read more

5/13/2022

5/13/2022

Convatec Welcomes Wound Care Sector Deal

Convatec Welcomes Wound Care Sector Deal

Read more